GlassScriptPhysician profile
Keri Eileen Robbins
NPI 1538758107
$7,252.96
in general payments reported to CMS, 2019-2025
33 companies · $2,401 in 2025
The $2,401 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.90 · 2022: $690 · 2023: $1,188 · 2024: $2,907 · 2025: $2,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,428 · Travel and Lodging: $1,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,428.17 |
| Travel and Lodging | $1,067.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,898.62 | 2023-2025 | Atriclip Laa Exclusion System |
| Aop Health US, LLC | $1,130.14 | 2025 | Rapiblyk |
| Janssen Pharmaceuticals, INC | $543.57 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $530.45 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $515.00 | 2022-2025 | |
| Amgen INC. | $355.86 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $329.91 | 2021-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Cds - Mct/Cem Monitoring |
| Abiomed | $261.99 | 2024-2025 | Impella |
| Philips North America LLC | $245.75 | 2023-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und, (Cm9) Amb Mon & Diag Und |
| Astrazeneca Pharmaceuticals LP | $244.24 | 2023-2025 | Brilinta, Andexxa |
| Abbott Laboratories | $227.64 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Jot Dx |
| Merck Sharp & Dohme LLC | $154.51 | 2022-2025 | Verquvo, Capvaxive |
| Pfizer INC. | $137.14 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $98.08 | 2022-2025 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $74.80 | 2022-2025 | Camzyos, Eliquis |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $62.44 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $59.18 | 2022-2023 | |
| Medtronic, INC. | $47.72 | 2023-2024 | Linq II, Symplicity G3, Corevalve Evolut R |
| Heartflow, INC. | $37.55 | 2025 | |
| Edwards Lifesciences Corporation | $34.21 | 2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.66 | 2022-2025 | Jardiance |
| Bridgebio Pharma, INC. | $28.89 | 2025 | Attruby |
| Actelion Pharmaceuticals US, INC. | $26.33 | 2021-2023 | Uptravi, Opsumit |
| Chiesi USA, INC. | $25.53 | 2025 | Kengreal |
| Kestra Medical Technology Services, INC. | $24.04 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $22.99 | 2025 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $17.62 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $17.43 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.89 | 2024 | |
| Esperion Therapeutics, INC. | $14.66 | 2022 | |
| Davol INC. | $14.28 | 2025 | Arista |
| Cardiva Medical, INC. | $13.93 | 2023 | Cardiva Vascade 6/7f Vcs |
| Lexicon Pharmaceuticals, INC. | $13.91 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keri Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.